CANTLEY, LEWIS C.,VANDER HEIDEN, MATTHEW G.,CHRISTOFK, HEATHER R.
申请号：
CA2659956
公开号：
CA2659956C
申请日:
2007.08.06
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention provides pharmaceutical compositions, kits, and methods of treating cancer, diabetes, obesity, autoimmune disease, and benign prostatic hyperplasia using compounds that selectively inhibit pyruvate kinase M2 and an assay measuring chemical modulation of pyruvate kinase activity.
